Advancements in antibody technologies and protein data are driving new possibilities in cancer research, enabling the identification of novel biomarkers and enhancing therapeutic strategies. In this ...

To describe a case of Progressive Encephalopathy with or without Lipodystrophy (PELD), characterized by a late onset of neurological regression at 9 years old, due to a homozygous c.974dupG variant in ...

Septerna Inc. has announced its decision to discontinue a healthy volunteer phase I trial of SEP-786, an oral small-molecule agonist of the parathyroid hormone 1 receptor being developed for the ...

Savefor later Page saved! You can go back to this later in your Diabetes and Me Close ...